Targeted sequencing of 72 prostate cancer driver in 712 plasma cell free DNA samples
Targeted sequencing of 72 prostate cancer driver in 712 plasma cell free DNA samples
- 19/07/2018
- 1140 samples
- DAC: EGAC00001000962
- Technology: Illumina HiSeq 2500
Data Access Policy for the DNA sequencing study included in the study "Frequent mutation of the FOXA1 untranslated region in prostate cancer"
A data access agreement (DAA), based on the example DAA provided by EGA, is to be filled out by the requester, and then by the data access committee (DAC) for the study "Frequent mutation of the FOXA1 untranslated region in prostate cancer".
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001003113 | Other |
